BEAM Beam Therapeutics Inc.

HealthcareBiotechnology
$31.47
▼ 2.69%
38
QScore Signal
Short
Confidence: MEDIUM
Long-Term
27
Short-Term
49

Value

14
P/E-49.96
8
P/B2.79
46
P/S24.44
0
EV/EBITDA-45.27
5

Growth

67
Revenue Growth120.0%
100
EPS Growth82.3%
49
FCF Growth-1.1%
44

Momentum

86
12-Month Return96.8%
100
3-Month Return27.3%
100
1-Month Return23.7%
96
RSI (14)50.22
50
50/200 MABullish
75

Profitability

11
ROE-5.9%
50
ROA-4.4%
3
Gross Margin-64.2%
0
Operating Margin-281.0%
0
Net Margin-49.2%
0
FCF Yield-11.9%
0

Risk

9
Beta2.26
20
60-Day Volatility71.3%
0

Generated 5/7/2026, 10:51:06 PM · How is this calculated?

QScore Analysis